AVIXAA Evidence-Based Skincare Solutions represent a paradigm shift from retail cosmetic moisturizers to targeted physiological wound healing and melanogenesis regulation. Specifically engineered for post-procedure recovery following chemical peels, ablative or fractional laser resurfacing, RF microneedling, and clinical dermabrasion.
Unlike commercial cosmetic lines, every AVIXAA topical formulation is developed under pharmaceutical cleanroom standards, free of fragrance, parabens, emulsifying waxes, or comedogenic oils that induce contact dermatitis in compromised stratum corneum.
Featured Formulations in This Portfolio
- Post-Procedure Restorative Barrier Cream: Formulated with a biomimetic 3:1:1 molar ratio of physiological ceramides, cholesterol, and free fatty acids synergized with purified Centella Asiatica madecassoside to cut re-epithelialization time by up to 48%.
- Melano-Regulator Depigmenting Serum: A dual-pathway tyrosinase and melanosome-transfer inhibitor utilizing encapsulated 5% Tranexamic Acid, Alpha-Arbutin, and Hexylresorcinol for stubborn epidermal melasma.
- Lipid-Restorative Soothing Emulsion: Designed for atopic or acutely reactive post-intervention skin, restoring transepidermal barrier integrity without occlusion or follicular blockage.
- Micro-Molecular Hyaluronic Barrier Mist: Sterile isotonic hydration spray engineered to maintain moist wound healing parameters during procedural recovery.
Every product is backed by in-vivo transepidermal water loss (TEWL) reduction trials and patch testing under the supervision of board-certified dermatologists.
Post-Procedure Barrier Cream
Biomimetic 3:1:1 physiological lipids + madecassoside for rapid stratum corneum re-epithelialization following lasers and peels.
Melano-Regulator Depigmenting Serum
Encapsulated 5% tranexamic acid, alpha-arbutin, and hexylresorcinol targeting refractory epidermal hyperpigmentation.
Clinical Transformation & Recovery Timeline
Clinical trial data demonstrated a 67% reduction in post-inflammatory erythema within 72 hours of application following fractional CO2 laser procedures:
